Research project
DGU.PROY.17
ProID2017010094. Desarrollo de nuevos medicamentos para el tratamiento de la tuberculosis pediátrica: formas farmacéuticas de administración oral.
date_range
Duration: from 15 September 2017 to 30 April 2021
(43 meses)
Researchers
Publications related to the project
Show by type2021
2020
-
Desarrollo y caracterización de formulaciones farmacéuticas adaptadas para pediatría
Javier Suárez González
-
Design and optimization of a child-friendly dispersible tablet containing isoniazid, pyrazinamide, and rifampicin for treating tuberculosis in pediatrics
Drug Development and Industrial Pharmacy
-
Stability study of isoniazid and rifampicin oral solutions using hydroxypropyl-Β-cyclodextrin to treat tuberculosis in paediatrics
Pharmaceutics